Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1990 2
1992 3
1993 2
1994 4
1995 5
1996 5
1997 4
1998 5
1999 2
2000 2
2001 6
2002 2
2003 1
2004 3
2005 6
2006 3
2007 3
2008 6
2009 11
2010 11
2011 12
2012 6
2013 5
2014 7
2015 20
2016 19
2017 14
2018 11
2019 18
2020 13
2021 9
2022 21
2023 16

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Results by year

Filters applied: . Clear all
Page 1
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial.
Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A. Katzenschlager R, et al. Among authors: van laar t. Lancet Neurol. 2018 Sep;17(9):749-759. doi: 10.1016/S1474-4422(18)30239-4. Epub 2018 Jul 25. Lancet Neurol. 2018. PMID: 30055903 Clinical Trial.
Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease.
Verschuur CVM, Suwijn SR, Boel JA, Post B, Bloem BR, van Hilten JJ, van Laar T, Tissingh G, Munts AG, Deuschl G, Lang AE, Dijkgraaf MGW, de Haan RJ, de Bie RMA; LEAP Study Group. Verschuur CVM, et al. Among authors: van laar t. N Engl J Med. 2019 Jan 24;380(4):315-324. doi: 10.1056/NEJMoa1809983. N Engl J Med. 2019. PMID: 30673543 Clinical Trial.
Levodopa Response in Patients With Early Parkinson Disease: Further Observations of the LEAP Study.
Frequin HL, Schouten J, Verschuur CVM, Suwijn SR, Boel JA, Post B, Bloem BR, van Hilten JJ, van Laar T, Tissingh G, Munts AG, Dijk JM, Deuschl G, Lang A, Dijkgraaf MGW, de Haan RJ, de Bie RMA; LEAP Study Group. Frequin HL, et al. Among authors: van laar t. Neurology. 2023 Jan 24;100(4):e367-e376. doi: 10.1212/WNL.0000000000201448. Epub 2022 Oct 17. Neurology. 2023. PMID: 36253105 Clinical Trial.
Fallacious falls.
Voermans NC, Zwarts MJ, van Laar T, Tijssen MA, Bloem BR. Voermans NC, et al. Among authors: van laar t. J Neurol. 2005 Oct;252(10):1271-3. doi: 10.1007/s00415-005-0033-7. Epub 2005 Sep 19. J Neurol. 2005. PMID: 16163551 No abstract available.
Infusion Therapies in the Treatment of Parkinson's Disease.
van Laar T, Chaudhuri KR, Antonini A, Henriksen T, Trošt M. van Laar T, et al. J Parkinsons Dis. 2023;13(5):641-657. doi: 10.3233/JPD-225112. J Parkinsons Dis. 2023. PMID: 37334617 Free PMC article. Review.
Visual hallucinations in psychosis.
van Ommen MM, van Laar T, Cornelissen FW, Bruggeman R. van Ommen MM, et al. Among authors: van laar t. Psychiatry Res. 2019 Oct;280:112517. doi: 10.1016/j.psychres.2019.112517. Epub 2019 Aug 10. Psychiatry Res. 2019. PMID: 31446216 Clinical Trial.
Supine MDS-UPDRS-III Assessment: An Explorative Study.
Kremer NI, Smid A, Lange SF, Mateus Marçal I, Tamasi K, van Dijk JMC, van Laar T, Drost G. Kremer NI, et al. Among authors: van laar t. J Clin Med. 2023 Apr 25;12(9):3108. doi: 10.3390/jcm12093108. J Clin Med. 2023. PMID: 37176549 Free PMC article.
233 results